Precision Diagnostics Market Synopsis:
Precision Diagnostics Market Size Was Valued at USD 15.6 Billion in 2023, and is Projected to Reach USD 71.33 Billion by 2032, Growing at a CAGR of 18.4% From 2024-2032.
Precision diagnostics market can be defined as the industry segment dedicated to creating innovative testing solutions and methods that can accurately diagnose ailments at their early stages. This market comprises various tools such as genomic sequencing, proteomics, and metabolomics, enabling customised therapy based on Genomic and Molecular traits. Through promoting better accuracy of the diagnosis and individualized treatments, precision diagnostics optimizes the benefits of the treatment for patients and, in contrast, reduces the probability of side effects of generalized treatments.
Among the primary growth drivers for the Precision Diagnostics Market is a continually growing incidence rate of chronic diseases, including cancer and cardiovascular diseases, which require an accurate and timely diagnosis. Since the healthcare providers are seeking to offer an individualized therapeutic approach, there is an increased need for an efficient diagnostic tool to describe the peculiarities of diseases nature. This trend is further supported by ongoing developments in NGS and biomarker discovery, for example, which strengthen the approach of precision diagnostics.
Also, the changing healthcare economy, currently trending towards value-based care is also driving the Precision Diagnostics Market. Payers and providers are concerned with concerns related to delivering quality care at a lower cost; this means that accurate diagnosis capabilities are crucial. Precision diagnostics allow for the choice to be made based upon the patient’s data and avoid unnecessary interventions while increasing the efficacy of the treatment. The deployment of EHR and big data analytics brings an even bigger change in healthcare systems by helping with the stratification and management of patients.
Precision Diagnostics Market Trend Analysis:
Growing integration of artificial intelligence (AI) and machine learning (ML) in diagnostic processes.
- One of the trends observed in the Precision Diagnostics Market is the active application of artificial intelligence (AI) and machine learning (ML) in diagnostics. Such technologies improve data processing potential thus accelerating the speed of interpreting intricate diagnostics outcomes. It can also sort big data and analyze it in a much shorter time than it would take a healthcare provider, and help them in clinical decision making. Besides making the diagnosis faster, it also assists doctors in the early detection of diseases enhancing patients’ positive impacts of their illnesses.
- The second major trend is the growing interest in liquid biopsies – minimally invasive diagnostics that study circulating tumor DNA (ctDNA) and other markers based on the blood test. Liquid biopsies have several advantages over tissue biopsies such as: Lower invasiveness and less risk and patient discomfort and providing continual real time updates on disease status and treatment efficacy. Innovation in the research and technology in this area is possible to posit liquid biopsies to be integrated part of precision diagnostics hence consequent boosting the market.
Emerging markets where healthcare infrastructure is rapidly evolving
- Reflected in the Precision Diagnostics Market, these opportunities are even more evident in the large emerging economies with a weak healthcare industry. With the continuing growth of knowledge in the new therapeutic tactics referred to as precision medicine, the demand for enhanced diagnostic tools in the Asian-Pacific and Latin American countries is constantly higher. It means investments in new technologies in health care and cooperation of governments along with private organizations will raise the community’s access to precise diagnostic tools and improve patients’ outcomes by timely diagnosing health issues.
- In addition, the future advancements and possibilities in the field of genomics and proteomics give chances to deliver more products. The firms that choose careful and effective approaches for the development of diagnostics, oriented to certain diseases or certain patient groups, can obtain the competitive advantage. With the focus shifting to precision medicine, research won’t be far from gaining enhanced funding and support to boost environments that facilitate discovery of precision diagnostic tools.
Precision Diagnostics Market Segment Analysis:
Precision Diagnostics Market is Segmented on the basis of Product type, Technology, application, end user, and Region
By Product Type, Consumables segment is expected to dominate the market during the forecast period
- The Precision Diagnostics Market is categorized into three primary product types: The assets that are in use where the cost of getting back together is immaterial are categorized as consumables, instruments, and software. Consumables include products with diagnostic enzymes, wafers, testing kits, strips and other reagents employed in the accurate determination of tests conducted to check abnormalities. Instruments also consist of the complex equipment and tools utilized in diagnostic procedures, that is, sequencers, analyzers, and imageers through which healthcare professionals make accurate diagnostic reports. Finally, software is used to store, process and present information and results for decision making by the healthcare providers based on large datasets. Altogether, these product types help achieve higher efficiency and effectiveness of precise diagnostics which leads to improved patients’ outcomes due to the instrumentalization of medicine.
By Application, Oncology segment expected to held the largest share
- The Precision Diagnostics segmented by application into oncology, infectious diseases, cardiovascular diseases, neurological disorders and others. One of the largest segments is oncology since precise diagnostics is critical in determining the particular type of cancer and creating individual therapies for a client, which would result in a higher quality of the services provided. Infectious diseases are also enhanced by precision diagnostics that will ensure that the causative organisms are identified quickly and accurately to ensure that the appropriate interventions are instituted. Another important set is cardiovascular diseases, when using new methods to diagnose the risks for such diseases as heart diseases can be detected on time. Diseases of the central nervous system such as Alzheimer’s disease and Parkinson’s disease have become more reliant on precision diagnosis in order to administer early correct diagnoses and tailored treatments. Other includes various other disorders: metabolic disorders and genetic diseases are also included in the category that indicates the applicability of the precision diagnostics in the various disorders in the human body.
Precision Diagnostics Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- North America has the largest market share in Precision Diagnostics Market owing to advanced health care facility, sound regulatory norms and good R and D investment. The region is populated by a lot of industry leading organizations that offer precision diagnostics hence helping the region to grow and innovate. In addition, the rise in incidence of chronic diseases and an ageing population in North America is fuelling the market for better diagnostic methods. With ongoing changes in exposure to personalized healthcare services, North America is likely to occupy its position as the market’s dominant region.
- Besides that, the North American market heavily relies on government support and funding to support further development of precision medicine initiatives. Precise diagnostics drive the NIH and the FDA to support the research and innovation of such products. Such endeavours in conjunction with collaborations between academia and industry promote the development of needed diagnostic technologies. Therefore, the Precision Diagnostics Market across North America is expected to experience further progress in the future.
Active Key Players in the Precision Diagnostics Market:
- Illumina, Inc. (United States)
- Thermo Fisher Scientific, Inc. (United States)
- Roche Diagnostics (Switzerland)
- Abbott Laboratories (United States)
- Qiagen N.V. (Netherlands)
- Agilent Technologies, Inc. (United States)
- PerkinElmer, Inc. (United States)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Hologic, Inc. (United States)
- Becton, Dickinson and Company (United States)
- Other Active Players
|
Precision Diagnostics Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 15.6 Billion |
|
Forecast Period 2024-32 CAGR: |
18.4% |
Market Size in 2032: |
USD 71.33 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
By Technology |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Precision Diagnostics Market by Products Type
4.1 Precision Diagnostics Market Snapshot and Growth Engine
4.2 Precision Diagnostics Market Overview
4.3 Consumables
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Consumables: Geographic Segmentation Analysis
4.4 Instruments
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Instruments: Geographic Segmentation Analysis
4.5 Software
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Software: Geographic Segmentation Analysis
Chapter 5: Precision Diagnostics Market by Technology
5.1 Precision Diagnostics Market Snapshot and Growth Engine
5.2 Precision Diagnostics Market Overview
5.3 Genomics
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Genomics: Geographic Segmentation Analysis
5.4 Proteomics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Proteomics: Geographic Segmentation Analysis
5.5 Metabolomics
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Metabolomics: Geographic Segmentation Analysis
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation Analysis
Chapter 6: Precision Diagnostics Market by Application
6.1 Precision Diagnostics Market Snapshot and Growth Engine
6.2 Precision Diagnostics Market Overview
6.3 Oncology
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Oncology: Geographic Segmentation Analysis
6.4 Infectious Diseases
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Infectious Diseases: Geographic Segmentation Analysis
6.5 Cardiovascular Diseases
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Cardiovascular Diseases: Geographic Segmentation Analysis
6.6 Neurological Disorders
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Neurological Disorders: Geographic Segmentation Analysis
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation Analysis
Chapter 7: Precision Diagnostics Market by End User
7.1 Precision Diagnostics Market Snapshot and Growth Engine
7.2 Precision Diagnostics Market Overview
7.3 Hospitals
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Hospitals: Geographic Segmentation Analysis
7.4 Diagnostic Laboratories
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Diagnostic Laboratories: Geographic Segmentation Analysis
7.5 Research Institutions
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Research Institutions: Geographic Segmentation Analysis
7.6 Others
7.6.1 Introduction and Market Overview
7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.6.3 Key Market Trends, Growth Factors and Opportunities
7.6.4 Others: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Precision Diagnostics Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 ILLUMINA INC. (UNITED STATES)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 THERMO FISHER SCIENTIFIC INC. (UNITED STATES)
8.4 ROCHE DIAGNOSTICS (SWITZERLAND)
8.5 ABBOTT LABORATORIES (UNITED STATES)
8.6 QIAGEN N.V. (NETHERLANDS)
8.7 AGILENT TECHNOLOGIES INC. (UNITED STATES)
8.8 PERKINELMER INC. (UNITED STATES)
8.9 F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND)
8.10 HOLOGIC INC. (UNITED STATES)
8.11 BECTON
8.12 DICKINSON AND COMPANY (UNITED STATES)
8.13 OTHER ACTIVE PLAYERS
Chapter 9: Global Precision Diagnostics Market By Region
9.1 Overview
9.2. North America Precision Diagnostics Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Products Type
9.2.4.1 Consumables
9.2.4.2 Instruments
9.2.4.3 Software
9.2.5 Historic and Forecasted Market Size By Technology
9.2.5.1 Genomics
9.2.5.2 Proteomics
9.2.5.3 Metabolomics
9.2.5.4 Others
9.2.6 Historic and Forecasted Market Size By Application
9.2.6.1 Oncology
9.2.6.2 Infectious Diseases
9.2.6.3 Cardiovascular Diseases
9.2.6.4 Neurological Disorders
9.2.6.5 Others
9.2.7 Historic and Forecasted Market Size By End User
9.2.7.1 Hospitals
9.2.7.2 Diagnostic Laboratories
9.2.7.3 Research Institutions
9.2.7.4 Others
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Precision Diagnostics Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Products Type
9.3.4.1 Consumables
9.3.4.2 Instruments
9.3.4.3 Software
9.3.5 Historic and Forecasted Market Size By Technology
9.3.5.1 Genomics
9.3.5.2 Proteomics
9.3.5.3 Metabolomics
9.3.5.4 Others
9.3.6 Historic and Forecasted Market Size By Application
9.3.6.1 Oncology
9.3.6.2 Infectious Diseases
9.3.6.3 Cardiovascular Diseases
9.3.6.4 Neurological Disorders
9.3.6.5 Others
9.3.7 Historic and Forecasted Market Size By End User
9.3.7.1 Hospitals
9.3.7.2 Diagnostic Laboratories
9.3.7.3 Research Institutions
9.3.7.4 Others
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Precision Diagnostics Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Products Type
9.4.4.1 Consumables
9.4.4.2 Instruments
9.4.4.3 Software
9.4.5 Historic and Forecasted Market Size By Technology
9.4.5.1 Genomics
9.4.5.2 Proteomics
9.4.5.3 Metabolomics
9.4.5.4 Others
9.4.6 Historic and Forecasted Market Size By Application
9.4.6.1 Oncology
9.4.6.2 Infectious Diseases
9.4.6.3 Cardiovascular Diseases
9.4.6.4 Neurological Disorders
9.4.6.5 Others
9.4.7 Historic and Forecasted Market Size By End User
9.4.7.1 Hospitals
9.4.7.2 Diagnostic Laboratories
9.4.7.3 Research Institutions
9.4.7.4 Others
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Precision Diagnostics Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Products Type
9.5.4.1 Consumables
9.5.4.2 Instruments
9.5.4.3 Software
9.5.5 Historic and Forecasted Market Size By Technology
9.5.5.1 Genomics
9.5.5.2 Proteomics
9.5.5.3 Metabolomics
9.5.5.4 Others
9.5.6 Historic and Forecasted Market Size By Application
9.5.6.1 Oncology
9.5.6.2 Infectious Diseases
9.5.6.3 Cardiovascular Diseases
9.5.6.4 Neurological Disorders
9.5.6.5 Others
9.5.7 Historic and Forecasted Market Size By End User
9.5.7.1 Hospitals
9.5.7.2 Diagnostic Laboratories
9.5.7.3 Research Institutions
9.5.7.4 Others
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Precision Diagnostics Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Products Type
9.6.4.1 Consumables
9.6.4.2 Instruments
9.6.4.3 Software
9.6.5 Historic and Forecasted Market Size By Technology
9.6.5.1 Genomics
9.6.5.2 Proteomics
9.6.5.3 Metabolomics
9.6.5.4 Others
9.6.6 Historic and Forecasted Market Size By Application
9.6.6.1 Oncology
9.6.6.2 Infectious Diseases
9.6.6.3 Cardiovascular Diseases
9.6.6.4 Neurological Disorders
9.6.6.5 Others
9.6.7 Historic and Forecasted Market Size By End User
9.6.7.1 Hospitals
9.6.7.2 Diagnostic Laboratories
9.6.7.3 Research Institutions
9.6.7.4 Others
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Precision Diagnostics Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Products Type
9.7.4.1 Consumables
9.7.4.2 Instruments
9.7.4.3 Software
9.7.5 Historic and Forecasted Market Size By Technology
9.7.5.1 Genomics
9.7.5.2 Proteomics
9.7.5.3 Metabolomics
9.7.5.4 Others
9.7.6 Historic and Forecasted Market Size By Application
9.7.6.1 Oncology
9.7.6.2 Infectious Diseases
9.7.6.3 Cardiovascular Diseases
9.7.6.4 Neurological Disorders
9.7.6.5 Others
9.7.7 Historic and Forecasted Market Size By End User
9.7.7.1 Hospitals
9.7.7.2 Diagnostic Laboratories
9.7.7.3 Research Institutions
9.7.7.4 Others
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Precision Diagnostics Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 15.6 Billion |
|
Forecast Period 2024-32 CAGR: |
18.4% |
Market Size in 2032: |
USD 71.33 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
By Technology |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
